Success Metrics

Active Trials

9(90%)

Phase Distribution

Ph phase_1

50%

Ph phase_2

40%

Ph phase_3

10%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution10 total trials

Phase 1Safety & dosage

5(50.0%)

Phase 2Efficacy & side effects

4(40.0%)

Phase 3Large-scale testing

1(10.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(10)

Detailed Status

Recruiting9

Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

N/A

Most Advanced

Phase 3

Trials by Phase

Phase 15 (50.0%)

Phase 24 (40.0%)

Phase 31 (10.0%)

Trials by Status

recruiting990%

not_yet_recruiting110%

Recent Activity

9 active trials

Showing 5 of 10

not_yet_recruitingphase_3

A Trial of LBL-024 Combined With Platinum-based Chemotherapy for the Treatment of Advanced EP-NEC

NCT07720193

recruitingphase_1

A Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors

NCT05170958

recruitingphase_2

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]

NCT07111546

recruitingphase_1

A Trial of LBL-024 Monotherapy, LBL-024 Combined With LBL-007 or Toripalimab in Patients With Advanced Melanoma

NCT07099430

recruitingphase_2

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)]

NCT06783647

View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials

NCT07720193Phase 3

A Trial of LBL-024 Combined With Platinum-based Chemotherapy for the Treatment of Advanced EP-NEC

Not Yet Recruiting

NCT05170958Phase 1

A Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors

Recruiting

NCT07111546Phase 2

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]

Recruiting

NCT07099430Phase 1

A Trial of LBL-024 Monotherapy, LBL-024 Combined With LBL-007 or Toripalimab in Patients With Advanced Melanoma

Recruiting

NCT06783647Phase 2

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)]

Recruiting

NCT07331155Phase 2

A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)]

Recruiting

NCT07042802Phase 1

A Phase Ib/Ⅱ Clinical Trial of LBL-024 Combined With Paclitaxel in Patients With Platinum-resistant Ovarian Cancer

Recruiting

NCT07390383Phase 2

A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]

Recruiting

NCT06157827Phase 1

A Clinical Trial of LBL-024 Combined With Etoposide and Platinum in Patients With Advanced Neuroendocrine Carcinoma

Recruiting

NCT07281976Phase 1

A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast Cancer

Recruiting

All 10 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 10